生物活性 | |||
---|---|---|---|
描述 | MK-0557 is a highly selective, orally available neuropeptide Y5 receptor antagonist with a Ki of 1.6 nM. |
临床研究 | |||||
---|---|---|---|---|---|
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT00092859 | Obesity | Phase 3 | Completed | - | - |
NCT00533598 | Obesity | Phase 2 | Completed | - | - |
NCT00482430 | Paranoid Schizophrenia ... 展开 >> Schizophrenia 收起 << | Phase 2 | Completed | - | - |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.46mL 0.49mL 0.25mL |
12.30mL 2.46mL 1.23mL |
24.61mL 4.92mL 2.46mL |